1,4:3,6-dianhydro-2-O-[4-[(4-bromo-3-chlorophenyl)amino]-6-(methyloxy)quinazolin-7-yl]-5-O-(methylsulfonyl)-D-glucitol

ID: ALA3986082

PubChem CID: 134156813

Max Phase: Preclinical

Molecular Formula: C22H21BrClN3O7S

Molecular Weight: 586.85

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@@H]1CO[C@H]2[C@@H]1OC[C@@H]2OS(C)(=O)=O

Standard InChI:  InChI=1S/C22H21BrClN3O7S/c1-30-16-6-12-15(25-10-26-22(12)27-11-3-4-13(23)14(24)5-11)7-17(16)33-18-8-31-21-19(9-32-20(18)21)34-35(2,28)29/h3-7,10,18-21H,8-9H2,1-2H3,(H,25,26,27)/t18-,19+,20-,21-/m1/s1

Standard InChI Key:  PWDUFJSWDUGFRW-PLACYPQZSA-N

Molfile:  

     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
    1.1666  -18.5664    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9916  -18.5664    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.5791  -17.8520    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6390  -17.2936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1554  -16.0480    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9476  -16.8456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9817  -16.0022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2783  -16.7722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1022  -16.7281    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3149  -15.9307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6222  -15.4823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5781  -14.6584    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6840  -18.1173    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6101  -17.5283    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    2.6365  -15.2470    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    6.4299  -14.6553    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1487  -14.2456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1445  -13.4122    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4287  -13.0049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7135  -14.2422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7171  -13.4205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0039  -13.0073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2906  -13.4183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2898  -14.2459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0031  -14.6564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5748  -13.0058    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4287  -12.1757    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1383  -11.7643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8524  -12.1783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5675  -11.7618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5629  -10.9346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8454  -10.5274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1332  -10.9430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8606  -13.4189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2746  -10.5173    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    9.2840  -12.1710    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.0381  -19.3920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  8  1  0
  7  5  1  0
  5  6  1  0
  6  4  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  7  1  0
 11 12  1  6
  4 13  1  1
  8 14  1  1
  7 15  1  1
 20 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 21  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 20  2  0
 23 26  1  0
 24 12  1  0
 19 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 28  2  0
 26 34  1  0
 31 35  1  0
 30 36  1  0
 13  2  1  0
  2 37  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3986082

    ---

Associated Targets(Human)

EPHB4 Tchem Ephrin type-B receptor 4 (3198 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EPHA2 Tclin Ephrin type-A receptor 2 (3499 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERBB2 Tclin Receptor protein-tyrosine kinase erbB-2 (7851 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 586.85Molecular Weight (Monoisotopic): 584.9972AlogP: 3.69#Rotatable Bonds: 7
Polar Surface Area: 118.10Molecular Species: NEUTRALHBA: 10HBD: 1
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.59CX LogP: 3.57CX LogD: 3.56
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.41Np Likeness Score: -0.54

References

1.  (2009)  Receptor-type kinase modulators and methods of use, 

Source